Orrick Herrington & Sutcliffe LLP advised Rafael Pharmaceuticals on the deal. Rafael Pharmaceuticals, a clinical-stage oncology company, announced its proposed merger with Rafael Holdings, Inc., (NYSE: RFL)....
This content is for Standard 1 Year members only. LoginJoin Now